Cardiovascular Medications & NCLEX Safety — Anticoagulants, Antianginals, Antihypertensives, and Pharmacology Review | Chapter 50: Saunders NCLEX-PN Review
Cardiovascular Medications & NCLEX Safety — Anticoagulants, Antianginals, Antihypertensives, and Pharmacology Review | Chapter 50: Saunders NCLEX-PN Review
Chapter 50 of Saunders Comprehensive Review for the NCLEX-PN® Examination (7th Edition) by Linda Anne Silvestri and Angela E. Silvestri delivers a comprehensive pharmacology review of cardiovascular medications. It outlines drug classifications, mechanisms of action, adverse effects, lab monitoring requirements, and NCLEX-priority nursing interventions to ensure medication safety in clinical practice.
Watch the lecture above for the complete medication breakdown, then review the detailed NCLEX study notes below.

Anticoagulants & Antiplatelets
- Warfarin: Monitor PT/INR; antidote is phytonadione (vitamin K)
- Heparin & Enoxaparin: Monitor aPTT; antidote is protamine sulfate
- Antiplatelets: Aspirin, clopidogrel—monitor for GI bleeding, bruising
Thrombolytics
- Alteplase—administer within time window; contraindicated in active bleeding, recent surgery, or hemorrhagic stroke
- Bleeding precautions and use of aminocaproic acid for reversal
Cardiac Glycosides
- Digoxin—positive inotrope; monitor serum levels (0.5–2 ng/mL), watch for toxicity (nausea, vision changes, arrhythmias)
- Increased toxicity risk with hypokalemia
Antihypertensives
- Diuretics:
- Thiazide (HCTZ)—monitor potassium
- Loop (furosemide)—ototoxicity, electrolyte loss
- Potassium-sparing (spironolactone)—risk of hyperkalemia
- Alpha-blockers: Prazosin, doxazosin—orthostatic hypotension
- Central sympatholytics: Clonidine, methyldopa—dry mouth, rebound hypertension
- ACE inhibitors: Lisinopril—dry cough, hyperkalemia, angioedema
- ARBs: Losartan—similar to ACE inhibitors but no cough
Antianginals
- Nitrates (nitroglycerin)—sublingual, patch, or spray; monitor BP; prevent tolerance; safety with PDE-5 inhibitors
Beta Blockers & Calcium Channel Blockers
- Beta blockers: Metoprolol, propranolol—bradycardia, bronchospasm, masks hypoglycemia
- Calcium channel blockers: Diltiazem, verapamil—bradycardia, constipation, edema
Vasodilators
- Hydralazine, nitroprusside—monitor for orthostatic hypotension; nitroprusside risk for cyanide toxicity
Lipid-Lowering Agents
- Statins—monitor liver enzymes; report muscle pain (possible rhabdomyolysis)
- Bile acid sequestrants, nicotinic acid—GI side effects, flushing (prevent with aspirin)
Nursing Safety Priorities
- Lab monitoring—PT/INR, aPTT, electrolytes, liver function
- Patient teaching—dose timing, side effect recognition, adherence
- Drug interactions—avoid NSAIDs with anticoagulants, grapefruit juice with statins or calcium channel blockers
- Emergency protocols for overdose or adverse reaction
Conclusion
This chapter equips NCLEX-PN candidates with essential cardiovascular pharmacology knowledge, emphasizing safe administration, patient education, and critical monitoring for medication side effects.
Subscribe to Last Minute Lecture for more NCLEX-focused lectures and study resources.
View the full Saunders Comprehensive Review for the NCLEX-PN® Examination (7th Edition) playlist here: Complete NCLEX-PN Review Playlist
Comments
Post a Comment